Emerging therapeutic targets for the treatment of hepatic fibrosis

被引：72
|
作者：
Fagone, Paolo [1 ]
Mangano, Katia [1 ]
Pesce, Antonio [2 ]
Portale, Teresa Rosanna [2 ]
Puleo, Stefano [2 ]
Nicoletti, Ferdinando [1 ]
机构：
[1] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy
[2] Univ Catania, Dept Med & Surg Sci & Adv Technol, GF Ingrassia, Catania, Italy
来源：
DRUG DISCOVERY TODAY | 2016年 / 21卷 / 02期
关键词：
ATTENUATES LIVER FIBROSIS; STELLATE CELLS; SYSTEMIC-SCLEROSIS; INTERFERON-GAMMA; STEM-CELLS; EXPRESSION; INHIBITION; ACTIVATION; DISEASE; TRANSPLANTATION;
D O I：
10.1016/j.drudis.2015.10.015
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Fibrosis represents a response to chronic injury, aimed at maintaining organ integrity. Hepatic fibrosis is mainly related to chronic viral hepatitis B or C (HBV or HCV), alcoholic and nonalcoholic steatohepatitis (NASH), and biliary diseases. A deep understanding of the cellular and molecular mechanisms underlying liver fibrosis has enabled the development of 'pathogenetic tailored' therapeutic interventions. However, effective drugs to prevent or revert hepatic fibrosis are still lacking. In this review, we discuss the cellular populations and the molecular pathways involved in liver fibrogenesis as well as the novel approaches currently being tested in clinical trials.
引用
收藏
页码：369 / 375
页数：7
相关论文
共 50 条
  • [1] Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
    Samuel, Chrishan S.
    Hewitson, Timothy D.
    [J]. FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [2] Emerging therapeutic targets for osteoporosis treatment
    Chen, Minglei
    Qiao, Hongzhi
    Su, Zhigui
    Li, Huipeng
    Ping, Qineng
    Zong, Li
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (07) : 817 - 831
  • [3] Emerging therapeutic targets for treatment of leishmaniasis
    Sundar, Shyam
    Singh, Bhawana
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (06) : 467 - 486
  • [4] Therapeutic targets in the treatment of allograft fibrosis
    Mannon, RB
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) : 867 - 875
  • [5] Exploration of new therapeutic targets for viral hepatic fibrosis, alcoholic hepatic fibrosis, and non-alcoholic hepatic fibrosis
    Wang, Xiaoling
    Wang, Ying
    Li, Xuewei
    Qin, Shuo
    Xu, Jun
    Xie, Jun
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (16)
  • [6] Emerging Molecular Targets for the Treatment of Cystic Fibrosis
    Yang, Zhe
    Sun, Fei
    Li, Chunying
    [J]. CURRENT DRUG TARGETS, 2015, 16 (09) : 922 - 922
  • [7] Emerging Targets for the Treatment of Idiopathic Pulmonary Fibrosis
    Lucas, Matthew C.
    Budd, David C.
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 149 - 167
  • [8] Emerging insights into the role of matrix metalloproteases as therapeutic targets in fibrosis
    Afratis, Nikolaos A.
    Selman, Moises
    Pardo, Annie
    Sagi, Irit
    [J]. MATRIX BIOLOGY, 2018, 68-69 : 167 - 179
  • [9] Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications
    Yanagihara, Toyoshi
    Scallan, Ciaran
    Ask, Kjetil
    Kolb, Martin R. J.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (11) : 939 - 948
  • [10] Current and Emerging Approaches for Hepatic Fibrosis Treatment
    Li, Jingguo
    Tuo, Biguang
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2021, 2021
12345